(Q73456978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

editorial

0 references

title

Results of recent large cholesterol-lowering trials and implications for clinical management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A M Gotto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1663-1666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Range of serum cholesterol values in the population developing coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Myocardial ischaemia, risk factors and death from coronary heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Role of insulin resistance in human disease (syndrome X): an expanded definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Lipid-regulating and antiatherosclerotic therapy: current options and future approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

Reduced mortality associated with long-term postmenopausal estrogen therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900218-X

10.1016/S0002-9149(97)00218-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9202359%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference